Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial - Weishaupt, Carsten; Schneider, Stefan W. (The lancet. Haematology, 2016)
Gesehen am 11.02.2019